← Back to patent-cliff list
盐酸赛洛唑啉
Tier C — Watch / tradeXylometazoline Hydrochloride
诺华制药
Originator
1959
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：α-adrenoceptors
Brand：Otrivine、Otrivin、Novorin
Indications (approved)：鼻塞、鼻炎
Regional status
US
-
EU
无进展
2007-03-01
China
批准上市
1994-01-01
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Xylometazoline Hydrochloride?
Approved indications include: 鼻塞, 鼻炎.
When does the Xylometazoline Hydrochloride patent expire?
No public expiry year is available for Xylometazoline Hydrochloride yet; this page updates once verified.
How do I get a quote for Xylometazoline Hydrochloride intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-25